NEW YORK – Bruker reported after the close of the market on Monday that its second quarter revenues were down 13 percent year over year.
For the three months ended June 30, Billerica, Massachusetts-based Bruker reported revenues of $424.6 million, down from $490.2 million in Q2 2019 but beating the consensus Wall Street estimate of $390.9 million.
Organic revenue growth was 13 percent, with foreign exchange rates lowering revenues by 1 percent and acquisitions boosting growth by less than 1 percent.